A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis

Схожие документы

• A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
  по: Robert Zivadinov, et al.
  Опубликовано: (2015-03-01)
• Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
  по: Tao, Yazhong, et al.
  Опубликовано: (2015)
• Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
  по: Zivadinov, Robert, et al.
  Опубликовано: (2014)
• Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
  по: Dwyer, Michael G., et al.
  Опубликовано: (2015)
• Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy
  по: Hagemeier, J., et al.
  Опубликовано: (2012)